This volume has explored the global attempts to innovate the diagnostics of alzheimer’s disease (ad), by means of biomarkers or otherwise. This exploration exceeded the confines of memory clinics and research centres, but also included sites such as newspapers, policy documents, patient groups, general practitioners, and online diagnostics tools. The diversity of sites reflects the many faces and manifestations of ad: it is not just one thing but many. This diversity brings along that the very notion of the disease and how it should be addressed are elusive. Diagnosis can take many forms and play different roles, and is not equally important for everyone. Moreover, exploring the different sites where ad manifests itself shows that ideas of ...
Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease with no available effecti...
AbstractResearch on early diagnostics for Alzheimer's disease is supported by what has been labeled ...
International audienceINTRODUCTION: Diagnosis of Alzheimer's disease (AD) remains difficult to estab...
This volume has explored the global attempts to innovate the diagnostics of alzheimer’s disease (ad)...
This volume has explored the global attempts to innovate the diagnostics of Alzheimer’s disease (AD)...
Public announcements of breakthroughs in diagnosing alzheimer’s disease regularly appear in newspape...
This book explores international biomedical research and development on the early diagnosis of Alzhe...
International audienceThe New Criteria for the diagnosis of Alzheimer’s disease (AD), published by a...
In innovation policy discourse, clinical practice guidelines are often viewed as gatekeepers: they s...
Public announcements of breakthroughs in diagnosing Alzheimer’s disease regularly appear in newspape...
Research on early diagnostics for Alzheimer's disease is supported by what has been labeled as aging...
Investigation in the field of Alzheimer's disease (AD), the commonest cause of dementia, has been ve...
Research on early diagnostics for Alzheimer's disease is supported by what has been labeled as aging...
Alzheimer’s disease (AD), the most common form of dementia, is a progressive and debilitating neurod...
A recently published framework for the diagnosis of Alzheimer’s disease (AD) in research studies wou...
Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease with no available effecti...
AbstractResearch on early diagnostics for Alzheimer's disease is supported by what has been labeled ...
International audienceINTRODUCTION: Diagnosis of Alzheimer's disease (AD) remains difficult to estab...
This volume has explored the global attempts to innovate the diagnostics of alzheimer’s disease (ad)...
This volume has explored the global attempts to innovate the diagnostics of Alzheimer’s disease (AD)...
Public announcements of breakthroughs in diagnosing alzheimer’s disease regularly appear in newspape...
This book explores international biomedical research and development on the early diagnosis of Alzhe...
International audienceThe New Criteria for the diagnosis of Alzheimer’s disease (AD), published by a...
In innovation policy discourse, clinical practice guidelines are often viewed as gatekeepers: they s...
Public announcements of breakthroughs in diagnosing Alzheimer’s disease regularly appear in newspape...
Research on early diagnostics for Alzheimer's disease is supported by what has been labeled as aging...
Investigation in the field of Alzheimer's disease (AD), the commonest cause of dementia, has been ve...
Research on early diagnostics for Alzheimer's disease is supported by what has been labeled as aging...
Alzheimer’s disease (AD), the most common form of dementia, is a progressive and debilitating neurod...
A recently published framework for the diagnosis of Alzheimer’s disease (AD) in research studies wou...
Alzheimer’s disease (AD) is a slowly progressive neurodegenerative disease with no available effecti...
AbstractResearch on early diagnostics for Alzheimer's disease is supported by what has been labeled ...
International audienceINTRODUCTION: Diagnosis of Alzheimer's disease (AD) remains difficult to estab...